Report Categories
View AllRecent Articles
View All
IAC Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises 21
Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress
THM Q1 2026 Earnings Minimal EPS Reported No Revenue as Development Continues
Burford Capital Q1 2026 Earnings Significant EPS Disappointment Despite Positive Stock Movement
MDWD Q4 2025 Earnings Narrower Loss Beats Estimates as Operational Focus Continues